Displaying 1 - 100 of 163

Entry IdEntry TitleAgencyJudge UsernameJudge EmailJudge DateVisual quality: Do the photography and/or the illustrations add intrigue or stopping power to the message?Art direction: Does the art element make me want to look at the piece?Message quality: Does the copy clearly communicate the intended message?Overall effectiveness: How well did the piece accomplish the desired results based on the objectives and results described in the applicant’s submission?Total Score
167‘Reset psoriasis’ campaignLemieux BédardJuly 30, 20225551025
168‘Reset psoriasis’ campaignLemieux BédardMay 8, 2022334717
167‘Reset psoriasis’ campaignLemieux Bédardanthony.turowaturow@klick.comMay 11, 202211215
168‘Reset psoriasis’ campaignLemieux Bédardanthony.turowaturow@klick.comMay 11, 202211349
167‘Reset psoriasis’ campaignLemieux Bédardjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022334818
168‘Reset psoriasis’ campaignLemieux Bédardjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022334818
167‘Reset psoriasis’ campaignLemieux Bédardkris.riegerkris@mavenmm.comMay 18, 2022223512
168‘Reset psoriasis’ campaignLemieux Bédardkris.riegerkris@mavenmm.comMay 18, 2022222713
168‘Reset psoriasis’ campaignLemieux Bédardmazen.baradhymazen.baradhy@gmail.comMay 9, 202222228
167‘Reset psoriasis’ campaignLemieux Bédardmazen.baradhymazen.baradhy@gmail.comMay 9, 202222228
168‘Reset psoriasis’ campaignLemieux Bédardpatrick.massadpatrickm@paab.caMay 7, 2022334717
159#DrysolidarityUs CommunicationsMay 8, 2022444820
159#DrysolidarityUs Communicationsanthony.turowaturow@klick.comMay 11, 2022225615
159#DrysolidarityUs Communicationsjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022445922
159#DrysolidarityUs Communicationskris.riegerkris@mavenmm.comMay 18, 2022445922
159#DrysolidarityUs Communicationsmazen.baradhymazen.baradhy@gmail.comMay 9, 2022444820
158A global first – PAH Franchise CreativeThe Adpharm Inc.May 8, 2022344819
158A global first – PAH Franchise CreativeThe Adpharm Inc.anthony.turowaturow@klick.comMay 11, 202211248
158A global first – PAH Franchise CreativeThe Adpharm Inc.jennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022443718
158A global first – PAH Franchise CreativeThe Adpharm Inc.kris.riegerkris@mavenmm.comMay 18, 2022223613
158A global first – PAH Franchise CreativeThe Adpharm Inc.mazen.baradhymazen.baradhy@gmail.comMay 9, 2022332513
150ATTR-CM WebsiteToc Toc CommunicationsMay 8, 2022444820
150ATTR-CM WebsiteToc Toc Communicationsanthony.turowaturow@klick.comMay 11, 202222228
150ATTR-CM WebsiteToc Toc Communicationsjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022434718
150ATTR-CM WebsiteToc Toc Communicationsmazen.baradhymazen.baradhy@gmail.comMay 9, 2022433313
146COPD CampMEDUCOM Health Inc.July 30, 20225551025
146COPD CampMEDUCOM Health Inc.anthony.turowaturow@klick.comMay 11, 2022333716
146COPD CampMEDUCOM Health Inc.jennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022444820
146COPD CampMEDUCOM Health Inc.mazen.baradhymazen.baradhy@gmail.comMay 9, 2022332311
146COPD CampMEDUCOM Health Inc.patrick.massadpatrickm@paab.caMay 7, 2022445821
26Country Lead - Rare DiseaseTrois Prime / PfizerJuly 30, 20225551025
26Country Lead - Rare DiseaseTrois Prime / PfizerJuly 30, 20225551025
22CYSTIC FIBROSIS TREATMENT COUNSELLING TOOLNo Fixed Address Inc.July 30, 20225551025
164Dear MomMcCann HealthJuly 30, 20225551025
164Dear MomMcCann HealthJuly 30, 20225551025
165Dear MomMcCann HealthMay 8, 2022445922
164Dear MomMcCann Healthanthony.turowaturow@klick.comMay 11, 2022442616
165Dear MomMcCann Healthanthony.turowaturow@klick.comMay 11, 2022332513
164Dear MomMcCann Healthjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022443718
164Dear MomMcCann Healthkris.riegerkris@mavenmm.comMay 18, 2022332513
165Dear MomMcCann Healthmazen.baradhymazen.baradhy@gmail.comMay 9, 2022444820
164Dear MomMcCann Healthmazen.baradhymazen.baradhy@gmail.comMay 9, 2022444820
162Fan For LifeMcCann HealthMay 8, 2022433717
162Fan For LifeMcCann Healthanthony.turowaturow@klick.comMay 11, 2022443819
162Fan For LifeMcCann Healthjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022554923
162Fan For LifeMcCann Healthkris.riegerkris@mavenmm.comMay 18, 2022444820
162Fan For LifeMcCann Healthmazen.baradhymazen.baradhy@gmail.comMay 9, 2022554923
153Giving Men New Hope: Print and Digital Education Campaign on Advances in Prostate Cancer TreatmentBayer Canada, MediaPlanetJuly 30, 20225551025
153Giving Men New Hope: Print and Digital Education Campaign on Advances in Prostate Cancer TreatmentBayer Canada, MediaPlanetanthony.turowaturow@klick.comMay 11, 202211114
153Giving Men New Hope: Print and Digital Education Campaign on Advances in Prostate Cancer TreatmentBayer Canada, MediaPlanetjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022223512
153Giving Men New Hope: Print and Digital Education Campaign on Advances in Prostate Cancer TreatmentBayer Canada, MediaPlanetkris.riegerkris@mavenmm.comMay 18, 2022333615
153Giving Men New Hope: Print and Digital Education Campaign on Advances in Prostate Cancer TreatmentBayer Canada, MediaPlanetmazen.baradhymazen.baradhy@gmail.comMay 9, 202222228
153Giving Men New Hope: Print and Digital Education Campaign on Advances in Prostate Cancer TreatmentBayer Canada, MediaPlanetpatrick.massadpatrickm@paab.caMay 7, 2022334717
20GIVING PHYSICIANS THE OPPORTUNITY TO “TEST-DRIVE” DIFFERENT MEDICATIONS FOR TYPE 2 DIABETES.No Fixed Address Inc.July 30, 20225551025
20GIVING PHYSICIANS THE OPPORTUNITY TO “TEST-DRIVE” DIFFERENT MEDICATIONS FOR TYPE 2 DIABETES.No Fixed Address Inc.July 30, 20225551025
163HIV changed my lifeMcCann HealthJuly 30, 20225551025
163HIV changed my lifeMcCann Healthanthony.turowaturow@klick.comMay 11, 2022234716
163HIV changed my lifeMcCann Healthjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022444820
163HIV changed my lifeMcCann Healthkris.riegerkris@mavenmm.comMay 18, 2022443718
163HIV changed my lifeMcCann Healthmazen.baradhymazen.baradhy@gmail.comMay 9, 2022444416
163HIV changed my lifeMcCann Healthpatrick.massadpatrickm@paab.caMay 7, 2022444820
19It clicksLemieux Bédard Communications/Teva Canada InnovationJuly 30, 20225551025
154KabiCare Patient Support Program MaterialsSentrex Health SolutionsMay 8, 2022445922
154KabiCare Patient Support Program MaterialsSentrex Health Solutionsanthony.turowaturow@klick.comMay 11, 2022223512
154KabiCare Patient Support Program MaterialsSentrex Health Solutionsjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022222410
154KabiCare Patient Support Program MaterialsSentrex Health Solutionskris.riegerkris@mavenmm.comMay 18, 2022333716
154KabiCare Patient Support Program MaterialsSentrex Health Solutionsmazen.baradhymazen.baradhy@gmail.comMay 9, 2022333615
169Live Better With Psoriasisenergi PR Inc.July 30, 20225551025
152Live Better With Psoriasisenergi PR, Bausch HealthJuly 30, 20225551025
152Live Better With Psoriasisenergi PR, Bausch HealthJuly 30, 20225551025
169Live Better With Psoriasisenergi PR Inc.July 30, 20225551025
152Live Better With Psoriasisenergi PR, Bausch Healthanthony.turowaturow@klick.comMay 11, 202211114
169Live Better With Psoriasisenergi PR Inc.anthony.turowaturow@klick.comMay 11, 202211114
152Live Better With Psoriasisenergi PR, Bausch Healthjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022223512
152Live Better With Psoriasisenergi PR, Bausch Healthkris.riegerkris@mavenmm.comMay 18, 2022333716
169Live Better With Psoriasisenergi PR Inc.kris.riegerkris@mavenmm.comMay 18, 2022333716
152Live Better With Psoriasisenergi PR, Bausch Healthmazen.baradhymazen.baradhy@gmail.comMay 9, 202222329
169Live Better With Psoriasisenergi PR Inc.mazen.baradhymazen.baradhy@gmail.comMay 9, 202222329
169Live Better With Psoriasisenergi PR Inc.patrick.massadpatrickm@paab.caMay 7, 2022334818
21MULTIPLE MYELOMA ASSESSMENT PATHWAY (M.M.A.P.)No Fixed Address Inc.July 30, 20225551025
21MULTIPLE MYELOMA ASSESSMENT PATHWAY (M.M.A.P.)No Fixed Address Inc.July 30, 20225551025
156MULTIPLE MYELOMA ASSESSMENT PATHWAY (MMAP)NFA HealthMay 8, 2022334717
156MULTIPLE MYELOMA ASSESSMENT PATHWAY (MMAP)NFA Healthanthony.turowaturow@klick.comMay 11, 2022223512
156MULTIPLE MYELOMA ASSESSMENT PATHWAY (MMAP)NFA Healthjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022444921
156MULTIPLE MYELOMA ASSESSMENT PATHWAY (MMAP)NFA Healthmazen.baradhymazen.baradhy@gmail.comMay 9, 2022344718
161My Kesimpta Injection Training ApplicationTrois PrimeMay 8, 20225551025
145My Kesimpta Injection Training ApplicationTrois PrimeJuly 30, 20225551025
145My Kesimpta Injection Training ApplicationTrois Primeanthony.turowaturow@klick.comMay 11, 202211114
161My Kesimpta Injection Training ApplicationTrois Primeanthony.turowaturow@klick.comMay 11, 2022444820
161My Kesimpta Injection Training ApplicationTrois Primejennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022544922
145My Kesimpta Injection Training ApplicationTrois Primejennifer.dilworthjdilworthfreelance@gmail.comMay 9, 202211114
161My Kesimpta Injection Training ApplicationTrois Primekris.riegerkris@mavenmm.comMay 18, 2022333716
161My Kesimpta Injection Training ApplicationTrois Primemazen.baradhymazen.baradhy@gmail.comMay 9, 2022444820
145My Kesimpta Injection Training ApplicationTrois Primemazen.baradhymazen.baradhy@gmail.comMay 9, 202211114
170Neuropathology ‘Deep dive’ campaignLemieux BédardMay 8, 2022544821
170Neuropathology ‘Deep dive’ campaignLemieux Bédardanthony.turowaturow@klick.comMay 11, 2022434718
170Neuropathology ‘Deep dive’ campaignLemieux Bédardjennifer.dilworthjdilworthfreelance@gmail.comMay 9, 2022534820
170Neuropathology ‘Deep dive’ campaignLemieux Bédardkris.riegerkris@mavenmm.comMay 18, 2022442515
170Neuropathology ‘Deep dive’ campaignLemieux Bédardmazen.baradhymazen.baradhy@gmail.comMay 9, 2022443819
166Peritoneal dialysis ‘I could have stayed home’ campaignLemieux BédardJuly 30, 20225551025
Entry IdEntry TitleAgencyJudge UsernameJudge EmailJudge DateVisual quality: Do the photography and/or the illustrations add intrigue or stopping power to the message?Art direction: Does the art element make me want to look at the piece?Message quality: Does the copy clearly communicate the intended message?Overall effectiveness: How well did the piece accomplish the desired results based on the objectives and results described in the applicant’s submission?Total Score

Join our Mailing list!

Get all latest news about our programs, subscribe to our newsletter!